COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening of Athletes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02056990
Recruitment Status : Completed
First Posted : February 6, 2014
Last Update Posted : November 6, 2018
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. F. Staes, Universitaire Ziekenhuizen Leuven

Brief Summary:

Athletes have to participate in screenings in order to reduce injuries. Up-to-now most screenings are purely clinically based. Literature, however, indicates the importance of knowledge on deviant movement patterns as possible risk factors for injuries. From this perspective, the current project aims to measure movement patterns, gait and running in young athletes to optimise training and prevent injuries.

2D- and 3d registration methods, force plate data and pressure plate data will be used to document the performance of the athletes.


Condition or disease Intervention/treatment
Individual Differences Motor Activities Other: Advice

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 15 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Years
Official Title: Screening of Athletes for Prevention of Injury and Optimisation of Performance
Study Start Date : March 2014
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Group/Cohort Intervention/treatment
training advise Other: Advice



Primary Outcome Measures :
  1. Kinematic and kinetic data [ Time Frame: March - June 2014 (3 months) ]

    Angles at different joints will be investigated with 3D movement analysis methods. Kinetic data (joint moments) will be calculated with 3D movement analysis methods.

    Center of pressure measures will be calculated on the basis of force plate data.

    Gait, running, jumps, postural balance will be investigated. Plantar pressure parameters will be calculated on the basis of plantar pressure measurements.



Secondary Outcome Measures :
  1. 2 D parameters [ Time Frame: March - June 2014 (3 months) ]
    Video analysis methods (Dartfish) will be used to calculate joint angles during jumps


Other Outcome Measures:
  1. Sports activities,personal demographics, injury history [ Time Frame: March - June 2014 (3 months) ]
    Sports activities, personal demographics and injury history will be documented through existing information from the medical department (Physical Rehabilitation of University Hospitals Leuven)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 22 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Athletes will be selected from a list offered by the Flemish Atlethics League. This incorporates a group of athletes with potential to become Elite Athletes of the highest international level
Criteria

Inclusion Criteria:

  1. Selected by the Flemish Athletics League
  2. Level: B1, B2 en C
  3. Age categories: 16-22 years
  4. No injuries at lower back and lower extremities in the past 6 months
  5. Signing informed consent

Exclusion Criteria:

  1. Not selected by the Flemish Athletics League
  2. Injuries at lower quadrant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02056990


Locations
Layout table for location information
Belgium
KU Leuven/UZLeuven
Leuven, Vlaams-Brabant, Belgium, 3000
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Investigators
Layout table for investigator information
Principal Investigator: Filip F Staes, Professor KU Leuven
Additional Information:

Layout table for additonal information
Responsible Party: Prof. Dr. F. Staes, Professor, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT02056990    
Other Study ID Numbers: S56252
First Posted: February 6, 2014    Key Record Dates
Last Update Posted: November 6, 2018
Last Verified: November 2018
Keywords provided by Prof. Dr. F. Staes, Universitaire Ziekenhuizen Leuven:
Athletes